Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06102525RecruitingPhase 1/Phase 2
Testing RZ-001 with valganciclovir for glioblastoma
This trial tests a new treatment called RZ-001 combined with an antiviral drug (valganciclovir) for people with glioblastoma, a serious brain tumor. The goal is to see if the combination is safe and can help shrink or slow the tumor.
IncheonAges 18 years+ - NCT06246656Recruiting
Maxillary expansion with a custom 3D-printed appliance
This trial tests a computer-designed device to widen the upper jaw. It may help people with a narrow upper jaw or a crossbite (when upper teeth sit inside lower teeth).
Vienna, State of ViennaAges 12–26 - NCT06406179Recruiting
Blood test for donor DNA in kidney transplant care
This trial is testing whether a simple blood test that looks for donor DNA can help doctors take better care of kidney transplant patients. It may help detect early signs of rejection and guide treatment decisions.
ParisAges 18 years+ - NCT06371755Recruiting
Comparing two bone density tests: ultrasound vs X-ray
This study compares two ways to measure bone density: a standard X-ray method (DXA) and a newer ultrasound method (REMS). If you are a woman scheduled for a DXA scan, you may help researchers see if the ultrasound test is just as accurate and easier to use.
Milan, MIAges 30–80 - NCT05476991RecruitingPhase 3
Low-dose colchicine plus ticagrelor to prevent repeat stroke
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
Paris, ParisAges 18 years+ - NCT06493318Recruiting
Wrist ligament surgery study: long-term results
This study looks at how well a specific wrist surgery (dorsal ligamentoplasty with an internal brace) works over time for people with scapholunate instability, a condition where the bones in the wrist are not stable. It aims to understand the long-term outcomes and help doctors know if this surgery is a good option.
MarseilleAges 18 years+ - NCT06507748Recruiting
Measuring pain with a finger device in NF1
This study tests a new way to measure pain and other sensations in people with NF1 using a device that clips onto a finger or toe. The device looks at how your pupil reacts to mild pulses, which may help doctors better understand your pain.
Washington D.C., District of ColumbiaAges 1–120 - NCT06152107Recruiting
BTVA Treatment for Severe Emphysema Study
This study tests a new bronchoscopic treatment called BTVA for people with severe emphysema. It uses heat to shrink damaged parts of the lung to improve breathing.
Zhengzhou, HenanAges 18 years+ - NCT06504732RecruitingPhase 2/Phase 3
IAH0968 plus CAPEOX for HER2-positive gastric cancer
This trial tests a new drug (IAH0968) combined with chemotherapy (CAPEOX) for people with HER2-positive stomach or gastroesophageal junction cancer that has not been treated before or has spread.
Harbin, HeilongjiangAges 18–75 - NCT06500884RecruitingPhase 2
Preventing mouth problems from GPRC5D therapy in myeloma
This study tests a preventive treatment for mouth or taste problems that can be caused by a newer type of multiple myeloma therapy. It aims to help people who have already tried several standard treatments and whose disease is still active.
San Francisco, CaliforniaAges 18 years+ - NCT06504043Enrolling by invitationPhase 1
Safety study of HST101 in healthy Chinese adults with high cholesterol
This study tests a new drug, HST101, to see if it is safe for healthy Chinese people with high cholesterol. It is an early-phase trial, so it focuses on safety first.
Chengdu, SichuanAges 18–55 - NCT06504290RecruitingPhase 1
Safety study of VV119 for healthy adults and people with schizophrenia
This trial tests if a new drug called VV119 is safe and how it works in the body. It is for healthy volunteers and for people who have had schizophrenia for at least a year and are currently having worsening symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT06496971RecruitingPhase 3
Testing focused ultrasound plus Avastin for recurrent glioblastoma
This study tests whether adding focused ultrasound to the standard drug Avastin (bevacizumab) can help treat recurrent glioblastoma. The ultrasound may help more of the drug reach the tumor.
TaipeiAges 18–80 - NCT06510205Recruiting
Long-term safety of Mentor breast implants in Chinese women
This study follows women who have Mentor breast implants for 5 years to check their long-term safety. It collects information from your medical records and follow-up visits to monitor how the implants are doing.
ChengduAges 18–100 - NCT06500702RecruitingPhase 2
Study of three drugs for FSGS or minimal change disease
This study tests three experimental drugs (frexalimab, brivekimig, and rilzabrutinib) for people ages 16 to 75 with a type of kidney disease called primary FSGS or minimal change disease. The goal is to see if these drugs can reduce protein in your urine and help protect your kidneys.
Birmingham, AlabamaAges 16–75 - NCT06500169Recruiting
Golf exercise study for prostate cancer survivors
This study tests if golf can help men with prostate cancer feel better and stay healthy. It's for men who are on hormone therapy and want to try a gentle, fun exercise.
Los Angeles, CaliforniaAges 55–85 - NCT06513910Recruiting
Studying how social music affects the brain
This trial looks at how listening to music with others changes brain activity. It may help us understand the social benefits of music.
New Haven, ConnecticutAges 16 years+ - NCT06511167Recruiting
Study of TIGR® Matrix in breast reconstruction after mastectomy
This study looks at how a special mesh called TIGR® Matrix affects quality of life, safety, and effectiveness after breast reconstruction surgery. It is for women who need or choose to have their breasts removed and reconstructed.
Weinheim, Baden-WurttembergAges 18 years+ - NCT06513065RecruitingPhase 3
Lower dose vs standard dose HIPEC for pseudomyxoma peritonei
This trial compares a lower dose of heated chemotherapy (HIPEC) given during surgery to a standard dose for patients with pseudomyxoma peritonei (a condition where jelly-like mucus builds up in the abdomen). The goal is to see if the lower dose works just as well with fewer side effects.
Basingstoke, HampshireAges 16 years+ - NCT06510868Recruiting
MDS risk study for NET patients before or after PRRT
This study looks at the risk of developing Myelodysplastic Syndrome (MDS), a blood disorder, in people with Neuroendocrine Tumors (NET) who are treated with Peptide Radionuclide Therapy (PRRT). It involves a simple blood test to check for genetic changes linked to MDS. Participating can help understand and potentially prevent this side effect.
Toronto, OntarioAges Any age - NCT06512064Recruiting
Breath sound analysis for lung health
This study tests a new device that listens to your breathing to check how well your lungs are working. It might help diagnose lung conditions without the need for forceful blowing tests, making it easier for patients.
Indianapolis, IndianaAges 8–70 - NCT06513858Enrolling by invitation
Community drum circle for wellness
This study looks at how a community drum circle may affect your wellbeing. It is open to anyone aged 16 and older.
New Haven, ConnecticutAges 16–65 - NCT06508892Recruiting
Using a fitness tracker to check fall risk
This study tests whether a fitness tracker or smartwatch can help detect your risk of falling. You will wear a device and do some simple movements, and the researchers will see if the device can warn you or your doctor about a fall risk.
Flint, MichiganAges 65 years+ - NCT06513871Enrolling by invitation
Social perception study for ages 16 and up
This study looks at how people understand social situations. It may help us learn more about social thinking in everyday life.
New Haven, ConnecticutAges 16–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.